Stock Market & Financial Investment News

News Breaks September 28, 2012 06:12 EDT JNJ DACOGEN approved in the EU for treatment of acute myeloid leukaemia Janssen-Cilag International NV announced that the European Commission has approved the marketing authorization for DACOGEN for the treatment of adult patients (age 65 years and above) with newly diagnosed de novo or secondary acute myeloid leukaemia, according to the World Health Organization classification, who are not candidates for standard induction chemotherapy. DACOGEN also has Orphan Drug designation for the treatment of AML. News For JNJ From The Last 14 Days Check below for free stories on JNJ the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 24, 2013 07:54 EDT JNJ Johnson & Johnson drug business should maintain momentum, says Wells Fargo After attending J&J's bi-annual pharmaceutical business review, Wells Fargo believes that the revenue generated by four of the company's new drugs could double from 2012 to 2015. The firm thinks the company's pharmaceutical unit has one of the best growth outlooks in the sector, and it keeps an Outperform rating on the stock. 06:28 EDT JNJ Johnson & Johnson price target raised to $94 from $88 at Leerink Subscribe for More Information May 23, 2013 10:08 EDT JNJ On The Fly: Analyst Initiation Summary Subscribe for More Information 07:31 EDT JNJ Janssen expects to have more than 25 brand line extensions by 2017 Subscribe for More Information 06:29 EDT JNJ Johnson & Johnson coverage assumed with an Underperform at Credit Suisse Subscribe for More Information May 22, 2013 16:00 EDT JNJ Options Update; May 22, 2013 Subscribe for More Information May 21, 2013 07:24 EDT JNJ Global Health Care to host a conference Subscribe for More Information May 17, 2013 06:19 EDT JNJ J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports Subscribe for More Information May 15, 2013 16:51 EDT JNJ FDA approves Simponi to treat ulcerative colitis Subscribe for More Information May 10, 2013 11:48 EDT JNJ Drugmakers to face pressure on U.S. prices, Reuters says Subscribe for More Information 06:16 EDT JNJ Obesity surgery booming in India, Bloomberg reports Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.